Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Impaired Cardiac cAMP-specific Phosphodiesterase-4/Beta-Adrenoceptors in a LAD-ligation Rat Model: Effect of Various Therapeutic Approaches
FY 2010-11
Summary
Heart failure represents the final common pathway for most forms of heart disease and continues to be a major clinical problem, despite recent therapy advances. The regulation of the heart's contraction is
achieved through the hormone noradrenaline interacting with 'receptor' molecules on the heart muscle cells. When noradrenaline binds the receptor, a cascade of events called 'signal transduction' is initiated, leading to the stimulation of heart contraction. A key link between noradrenaline and contraction is a molecule called cyclic-adenosine monophosphate (cAMP), with levels in the heart
increasing following activation of the noradrenaline receptor. In heart failure, noradrenaline levels are constantly elevated, with changes in the 'signal transduction' components leading to detrimental
changes in the structure and responsiveness of the heart.Measurement of the cAMP and the 'signal transduction' system would be useful in understanding the state of the heart's contractile ability. While the small molecule cAMP is difficult to measure, its levels are closely linked to the activity and quantity of a protein called phosphodiesterase-4 (PDE4) (also part of the 'signal transduction'). Our group has performed studies that indicate that this protein can be
measured using positron emission tomography (PET) imaging and a compound called rolipram, labeled with a radioactive isotope carbon-11. The objectives of the proposed project are to evaluate changes in the PDE4 levels and thereby cAMP 'signal transduction' following common heart failure therapy in a rat model of heart failure using non-invasive methods that can be easily applied in humans. Together these experiments will set the stage for future translation to human heart failure.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
226617
Name
Buttenaar Paige
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Impaired Cardiac cAMP-specific Phosphodiesterase-4/Beta-Adrenoceptors in a LAD-ligation Rat Model: Effect of Various Therapeutic Approaches
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiac Imaging; Cell Signalling Pathways; Heart Failure
Abstract
Heart failure represents the final common pathway for most forms of heart disease and continues to be a major clinical problem, despite recent therapy advances. The regulation of the heart's contraction is
achieved through the hormone noradrenaline interacting with 'receptor' molecules on the heart muscle cells. When noradrenaline binds the receptor, a cascade of events called 'signal transduction' is initiated, leading to the stimulation of heart contraction. A key link between noradrenaline and contraction is a molecule called cyclic-adenosine monophosphate (cAMP), with levels in the heart
increasing following activation of the noradrenaline receptor. In heart failure, noradrenaline levels are constantly elevated, with changes in the 'signal transduction' components leading to detrimental
changes in the structure and responsiveness of the heart.Measurement of the cAMP and the 'signal transduction' system would be useful in understanding the state of the heart's contractile ability. While the small molecule cAMP is difficult to measure, its levels are closely linked to the activity and quantity of a protein called phosphodiesterase-4 (PDE4) (also part of the 'signal transduction'). Our group has performed studies that indicate that this protein can be
measured using positron emission tomography (PET) imaging and a compound called rolipram, labeled with a radioactive isotope carbon-11. The objectives of the proposed project are to evaluate changes in the PDE4 levels and thereby cAMP 'signal transduction' following common heart failure therapy in a rat model of heart failure using non-invasive methods that can be easily applied in humans. Together these experiments will set the stage for future translation to human heart failure.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Buttenaar, Paige
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~